Praxis Provides Ongoing Vaccine Research Study with Retention Program

Brentwood, TN -- April, 27, 2006 -- Praxis, a company specializing in centralized patient recruitment and retention for clinical research studies, has signed on to implement a retention program for a major pharmaceutical company.  The study explores an investigational vaccine for a significant female health issue.

Praxis is providing several volunteer retention items including an informational newsletter, as well as items to show appreciation to volunteers for their ongoing commitment to the study. 

“This research has far reaching implications in the area of disease prevention,” said David Fox, president and CEO of Praxis. “It’s exciting for us to be a part of this program.” 

This long-term, Phase IIb study, focuses on a condition that affects 20 million people nationwide.  A total of 18 sites are conducting this study with 265 volunteers participating for a total of 36 months. 

Praxis Communications, Inc., headquartered in Brentwood, TN, provides the pharmaceutical and biotech industries with a wide range of services for patient recruitment and retention for clinical trials including patient profiling, recruitment planning, centralized fulfillment, media relations, advertising, and program management. For more information, call Praxis at (615) 312-8207.

> Back to Press Releases